Affiliation:
1. Department of Surgical Sciences, Section of Gynecology and Obstetrics University Tor Vergata Rome Italy
2. Department of Gynecological and Obstetrics Sandro Pertini Hospital Rome Italy
3. Department of Week‐Surgery, Campus Biomedico University of Rome Rome Italy
Abstract
AbstractObjectivesThe aim of this study was to compare the efficacy of the transobturator tape (TOT) procedure combined with solifenacin (TOT‐S) or prasterone (TOT‐P) in postmenopausal women affected by mixed urinary incontinence (MUI) with a predominant stress urinary incontinence component.MethodsThis is a retrospective analysis including 112 patients: 60 patients of the TOT‐S group and 52 patients of the TOT‐P group. Physical examination, 3‐day voiding diary, urodynamic tests, and Vaginal Health Index (VHI) were compared at the beginning of the analysis and after 12 weeks of follow‐up (FU). Specific questionnaires were administered to indagate the impact on women's quality of life and sexual function.ResultsAfter 12 weeks of FU, the detrusor's peak flow pressure was significantly different between the two groups (p = .02). Detrusor overactivity decreased only in the TOT‐P group (p = .05). At the end of FU, 58 patients (96.7%) of the TOT‐S group and 50 patients (96.2%) of the TOT‐P group were dry at the stress test. A significative group difference was observed in urge urinary incontinence (24 h) (p = .01) but not in the mean number of voids (24 h) and urgent micturition events (24 h). VHI improved only in the TOT‐P group (12.57 ± 3.80 vs. 19.75 ± 4.13, p < .0001). The questionnaires and Patient Global Index of Improvement (PGI‐I) scores showed comparable improvements, while the Female Sexual Function Index improved especially in the TOT‐P group (p < .001).ConclusionsIn postmenopausal women with MUI, TOT‐P demonstrated the same effectiveness as TOT‐S in reducing urinary symptoms. In addition, TOT‐P increased VHI and sexual function scores compared with TOT‐S.